Skip to content
  • Home
  • Contact
  • In The Spotlight
  • Serving Point
  • Home
  • About
FINPLATE
  • Serving Point
  • In The Spotlight
  • Contact
FINPLATE
  • In The Spotlight

Vimeo’s Shocking 28% Plummet: A Power Move or Market Woe?

  • Byfinplate.co
  • Published On26 March 2024
Vimeo's (NASDAQ: VMEO) 28% stock drop coincides with speculation of potential acquisition by Bending Spoons SpA amid its market cap of $912 million and a significant decline since its spin-off from IAC/Interactive Corp.
  • In The Spotlight

Blackstone’s £1.5 Billion Flex Office Power Play: Seizing Post-Pandemic Opportunities

  • Byfinplate.co
  • Published On25 March 2024
Blackstone explores £1.5 billion sale of The Office Group, aiming for gains amid WeWork's collapse, eyeing deal by Q1 2025 amidst rising demand for flexible office space.
  • In The Spotlight

Unstoppable Cartica: $40,000 Monthly Boost for Business Combination Deadline Extension!

  • Byfinplate.co
  • Published On24 March 2024
Cartica Acquisition Corp plans to extend its initial business combination deadline, with the Sponsor committing to contribute $40,000 monthly until January 7, 2025, contingent on shareholder approval, impacting per-share amounts and potential redemptions.
  • In The Spotlight

Breakthrough: AbbVie’s $10 Billion Immunogen Deal Clinches FDA Approval for Ovarian Cancer Drug!

  • Byfinplate.co
  • Published On23 March 2024
The FDA grants full approval for AbbVie's Elahere, a drug for treating ovarian cancer, following its initial accelerated approval in November 2022, based on data from the MIRASOL Phase 3 study, after AbbVie's acquisition of ImmunoGen for approximately $10 billion.
Prev1 … 28 29 30 31 32 33 34 … 50Next
No more posts to load

About Finplate

Serving bite-sized, easily digestible financial information and concepts to make finance accessible and understandable

Important Links

  • Privacy Policy
  • Disclaimer
  • Terms & Conditions

Useful Links

  • Home
  • About Us
  • News
  • Blog
  • Contact
  • LinkedIn
  • Mail